Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Epigenetics to Reverse Skin Ageing
9
Mins
November 2024
Epigenetic changes drive skin aging by silencing the expression of youthful genes. Experts discussed the discovery of epicelline, an…
Read more
8
Mins
10 Jan 2020
New Insights into Dimethyl Fumarate, an Oral Therapy for the Treatment of Plaque Psoriasis
Psoriasis is associated with high morbidity, causing problems in daily life such as itching and scaling, even for patients with less-severe disease…
4
Mins
19 Dec 2019
Connecting the Dots Between Skin and Allergy
Allergies represent a significant, rising health concern. Recent figures indicate that 150 million Europeans experience chronic allergic disease…
6
Mins
12 Dec 2019
IL-23 Inhibition: From Pathophysiological Jungle to Clinical Clearance
The symposium “IL-23 Inhibition: From Pathophysiological Jungle to Clinical Clearance” took place during the 2019 annual European Academy of Dermatology…
10
Mins
12 Dec 2019
Latest Highlights from Guselkumab in Psoriasis from EADV 2019
Guselkumab was the first monoclonal antibody targeting the p19 subunit of IL-23 (IL-23p19) to be approved for the treatment of psoriasis.
10
Mins
12 Dec 2019
Management of Moderate-to-Severe Atopic Dermatitis in the Era of Targeted Treatments
Prof Augustin opened the symposium by underlining how the management of patients with moderate-to-severe atopic dermatitis (AD) has become more dynamic…
9
Mins
26 Nov 2019
Psoriasis and Atopic Dermatitis: Addressing Therapeutic Paradigms by Learning from Each Other
Psoriasis and AD are chronic, systemic inflammatory diseases of the skin characterised by upregulation of proinflammatory cytokines…
9
Mins
26 Nov 2019
Editor's Pick: Acne Therapy Across Time in the USA
Acne is the most common skin condition in the USA, affecting over half of its population.1 It is an inflammatory skin disease that predominantly…
10
Mins
26 Nov 2019
Treatment of Atopic Dermatitis Using JAK Inhibitors: A Systematic Review
Atopic dermatitis (AD) is one of the most common and debilitating chronic inflammatory skin diseases, often greatly affecting physical, economical…
Loading posts...
« Previous
1
…
11
12
13
14
15
…
27
Next »